Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rigla is the largest pharmaceutical retail chain in Russia, operating as the retail business segment of the Protek Group. Founded in 2001, the company manages over 6,500 pharmacies across various regions of Russia under brands such as Rigla, Bud Zdorov! (Be Healthy!), and Zhivika. Rigla offers a wide range of pharmaceutical products, medical devices, and health and beauty goods, with an inventory of approximately 20,000 items. In addition to its retail operations, Rigla has expanded into private label drug production, launching several cold, flu, and over-the-counter medications. The company continues to grow aggressively through regional acquisitions of smaller pharmacy chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rigla.